Dermablend Professional SkinPerfector Redness Reducing Primer Sunscreen (L’Oreal USA Products Inc)
Welcome to the PulseAid listing for the Dermablend Professional SkinPerfector Redness Reducing Primer Sunscreen drug offered from L’Oreal USA Products Inc. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | L’Oreal USA Products Inc |
NON-PROPRIETARY NAME: | Avobenzone, Octisalate and Octocrylene |
SUBSTANCE NAME: | AVOBENZONE; OCTISALATE; OCTOCRYLENE |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | TOPICAL |
DOSAGE FORM: | LOTION |
MARKETING CATEGORY NAME: | OTC MONOGRAPH NOT FINAL |
START MARKETING DATE: | 2013-03-01 |
END MARKETING DATE: | 0000-00-00 |
Dermablend Professional SkinPerfector Redness Reducing Primer Sunscreen HUMAN OTC DRUG Details:
Item Description | Dermablend Professional SkinPerfector Redness Reducing Primer Sunscreen from L’Oreal USA Products Inc |
LABELER NAME: | L’Oreal USA Products Inc |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 20; 33; 46(mg/mL; mg/mL; mg/mL) |
START MARKETING DATE: | 2013-03-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 49967-105_7c568f28-5573-4f10-b4a0-97444fe9b979 |
PRODUCT NDC: | 49967-105 |
APPLICATION NUMBER: | part352 |
Other AVOBENZONE; OCTISALATE; OCTOCRYLENE Pharmaceutical Manufacturers / Labelers: